FDA Adverse Event Injury Summary report: N

UNKNOWN HIP COMPONENTS

MDR report key: 21698410 · Received March 26, 2025

Report

Report Number
1038671-2025-01663
Event Type
Injury
Date Received
March 26, 2025
Report Date
April 25, 2025
Manufacturer
EXACTECH, INC.
Product Code
JDI
Adverse Event
Yes
Report Source
Manufacturer report
Reporter Location
US
Reporter Occupation
003

Narratives

Additional Manufacturer Narrative · 0

THIS FOLLOW-UP REPORT IS BEING SUBMITTED TO RELAY CORRECTED INFORMATION. IF ANY FURTHER INFORMATION IS OBTAINED THAT WOULD CHANGE OR ALTER ANY INFORMATION PROVIDED, A SUPPLEMENTAL REPORT WILL BE FILED ACCORDINGLY.

Additional Manufacturer Narrative · 0

D10 CONCOMITANT DEVICES: 101-05-20 - 3.2MM DRILL BIT 20MM 1PK: 5381162; 136-36-52 - NV GXL LNR, +5LAT, 36MM G2-52/54MM CUPS: 3873814; 170-36-93 - BIOLOX DELTA FEM HEAD 36MM OD, -3.5MM: 5569548; 180-65-20 - ALTEON 6.5MM SCREW, 20MM: S003719; 186-01-54 - INTEGRIP CC, CLUSTER 54MM, G2: 5568168; 190-31-04 - ALT HA S CLR EXT SZ 4: 4896699. H3: THE REPORTED EVENT WAS UNABLE TO BE CONFIRMED DUE TO LIMITED INFORMATION RECEIVED FROM THE CUSTOMER. NO DEVICE WAS RETURNED FOR EVALUATION; FURTHER, PHOTOGRAPHS AND/OR RADIOGRAPH IMAGES WERE NOT PROVIDED FOR REVIEW. OPERATIVE NOTES AND/OR MEDICAL RECORDS WERE NOT PROVIDED FOR REVIEW OF USAGE/ TECHNIQUE. A DEFINITIVE ROOT CAUSE WAS UNABLE TO BE DETERMINED AS THE NECESSARY INFORMATION TO ADEQUATELY INVESTIGATE THE REPORTED EVENT WAS NOT PROVIDED. IF ANY FURTHER INFORMATION IS OBTAINED THAT WOULD CHANGE OR ALTER ANY INFORMATION PROVIDED, A SUPPLEMENTAL REPORT WILL BE FILED ACCORDINGLY.

Description of Event or Problem · 0

IT WAS REPORTED THAT THIS PATIENT'S LEFT HIP WILL BE REVISED IN THE NEAR FUTURE. PATIENT INDICATED THE IMPLANT WAS GETTING LOST AND GOT DEPLETED. NO FURTHER INFORMATION AVAILABLE.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
1694824 UNKNOWN HIP COMPONENTS PROSTHESIS, HIP, SEMI-CONSTRAINED, METAL/POLYMER, CEMENTED JDI EXACTECH, INC.

Patients

Seq Age Sex Outcome Treatment
1 NA Female Hospitalization| O SEE H11